Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study

BACKGROUND: Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment regimens and still standard of care in the combination with pegylated interferon (pegIFN) to treat chronic HCV in resource limited settings. Study results in HIV/HCV-coinfected patients are contradictin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Kovari, Helen, Russmann, Stefan, Ledergerber, Bruno, Müller, Daniel, Rotger, Margalida, Velli, Pablo, Cavassini, Matthias, Ambrosioni, Juan, Bregenzer, Andrea, Stöckle, Marcel, Bernasconi, Enos, Rauch, Andri, Speck, Roberto F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517877/
https://ncbi.nlm.nih.gov/pubmed/26218843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0133879
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky